FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 104 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,495,826 | +30.9% | 562,123 | -2.7% | 0.01% | +40.0% |
| Q2 2023 | $1,906,958 | +3.0% | 577,866 | -11.1% | 0.01% | 0.0% |
| Q1 2023 | $1,851,959 | +91.2% | 649,810 | +388.5% | 0.01% | +66.7% |
| Q4 2022 | $968,378 | -7.9% | 133,019 | -38.1% | 0.00% | 0.0% |
| Q2 2022 | $1,052,000 | +163.0% | 214,763 | +1170.8% | 0.00% | +200.0% |
| Q1 2022 | $400,000 | -95.7% | 16,900 | -96.8% | 0.00% | -95.0% |
| Q4 2021 | $9,216,000 | -48.4% | 520,990 | -17.6% | 0.02% | -50.0% |
| Q3 2021 | $17,844,000 | +10780.5% | 632,539 | +3951.9% | 0.04% | – |
| Q2 2021 | $164,000 | -0.6% | 15,611 | +11.7% | 0.00% | – |
| Q1 2021 | $165,000 | -49.1% | 13,979 | -49.4% | 0.00% | -100.0% |
| Q4 2020 | $324,000 | +256.0% | 27,647 | +140.4% | 0.00% | – |
| Q3 2020 | $91,000 | – | 11,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |